Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Cancer|April 15, 1993
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trialA Kritz, J P Crown, R J Motzer, et al.
International Journal of Oncology|July 17, 1998
Aminopeptidase A expression and enzymatic activity in primary human renal cancersD M Nanus, T Bogenrieder, C N Papandreou, et al.
ESMO Open|April 9, 2022
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
ESMO Open|October 22, 2023
Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologiesM H Voss, D A Bastos, C A Karlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Cancer|April 15, 1993
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trialA Kritz, J P Crown, R J Motzer, et al.
International Journal of Oncology|July 17, 1998
Aminopeptidase A expression and enzymatic activity in primary human renal cancersD M Nanus, T Bogenrieder, C N Papandreou, et al.
ESMO Open|April 9, 2022
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
ESMO Open|October 22, 2023
Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologiesM H Voss, D A Bastos, C A Karlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Pageof 16